Qingdao Huarentai Pharmaceutical Co., Ltd., Puyuan and stomach capsules, a well-known gastric medicine brand, mainly based on solid preparations of traditional Chinese medicine, supplemented by excellent western medicine, has a comprehensive production capacity of solution / tablet/capsule and other dosage forms and traditional Chinese medicine extraction as one of the multi-dosage form development
Qingdao Huarentai Pharmaceutical Co., Ltd. is a joint-stock enterprise established by Qingdao Haiyan Pharmaceutical Factory, an enterprise directly under the logistics department of the former North Sea Fleet, after carrying out the transformation of "military to civilian" and technological upgrading. At present, the company mainly focuses on solid preparations of traditional Chinese medicine and supplemented by excellent western medicine, and is a modern comprehensive pharmaceutical enterprise with high-tech as the leading and all-round development.
Qingdao Huarentai Pharmaceutical Co., Ltd. adheres to the business philosophy of "benevolence loves people, medicine benefits the world", takes promoting the development of China's health industry as its own responsibility, and aims to improve people's health, and always pays attention to the modernization, standardization and internationalization process of China's traditional Chinese medicine. The company adheres to the talent strategy of combining internal training and external introduction, has created a high-quality, professional and cohesive marketing team, established a marketing service network covering 19 provinces and municipalities directly under the central government and more than 60 prefecture-level cities, and is gradually growing into a model and example of R&D, production, operation and service in the national health industry.
After more than 40 years of development and accumulation, Huarentai Pharmaceutical has established three R&D and production bases in Licang District, Chengyang High-tech Zone and Fenghuang Town, Zhangjiagang City, covering a total area of nearly 200,000 square meters, and has a comprehensive production capacity for the production of more than 20 dosage forms such as solutions, tablets, capsules, etc., as well as multi-dosage forms for the extraction of traditional Chinese medicine.
At present, the company has dozens of international first-class production lines with national GMP standards and US FDA standards, and can produce more than 100 varieties of new traditional Chinese medicine Pu Yuan and stomach capsules, tonic and strong heart tablets and pelinita capsules with independent intellectual property rights, with an annual output of 2 billion tablets, 2 billion capsules, 20 million bags of granules and other dosage forms, with an annual output value of more than 2 billion yuan.
A new starting point, a new leap, starting from the acquisition of Suzhou Zilu Pharmaceutical Co., Ltd. and the establishment of Suzhou Huarentai Pharmaceutical Industry, Huarentai Pharmaceutical Industry is launching a new round of expansion. In the future, Huarentai Pharmaceutical Co., Ltd. will widely absorb the latest research results in the world's pharmaceutical field through mergers and acquisitions, holding and cooperative development, and actively build a national OTC drug marketing network while vigorously expanding the marketing network of hospital prescription drugs.
At the same time, through the nationwide market operation, the capitalization, branding, and international operation of the enterprise are realized, and it is committed to developing into a well-known listed pharmaceutical enterprise with diversified varieties and forward-looking technology, actively creating high-quality drugs for the society and the public, and escorting the life and health of the public.
